Sulfonated Penta-galloyl Glucose (SPGG): The Pharmacological Effects of Promiscuous Glycosaminoglycan Small Molecule Mimetic

References

1. ValletS.D. BerthollierC. Ricard-BlumS. The glycosaminogl-ycan interactome 2.0.Am. J. Physiol. Cell Physiol.20223226C1271C127810.1152/ajpcell.00095.202235544698
   [Google Scholar]
2. WardropD. KeelingD. The story of the discovery of heparin and warfarin.Br. J. Haematol.2008141675776310.1111/j.1365‑2141.2008.07119.x18355382
   [Google Scholar]
3. QiuM. HuangS. LuoC. WuZ. LiangB. HuangH. CiZ. ZhangD. HanL. LinJ. Pharmacological and clinical application of heparin progress: An essential drug for modern medicine.Biomed. Pharmacother.202113911156110.1016/j.biopha.2021.11156133848775
   [Google Scholar]
4. XuD. PrestegardJ.H. LinhardtR.J. Proteins that bind sulfated glycosaminoglycans.Essentials of Glycobiology.4th edCold Spring Harbor Laboratory Press2022
   [Google Scholar]
5. Al-HoraniR.A. KarS. Potential Anti-SARS-CoV-2 therapeutics that target the post-entry stages of the viral life cycle: A comprehensive review.Viruses20201210109210.3390/v1210109232993173
   [Google Scholar]
6. Al-HoraniR.A. KarS. AliterK.F. Potential Anti-COVID-19 therapeutics that block the early stage of the viral life cycle: Structures, mechanisms, and clinical trials.Int. J. Mol. Sci.20202115522410.3390/ijms2115522432718020
   [Google Scholar]
7. AfosahD.K. Al-HoraniR.A. Sulfated non-saccharide glycosaminoglycan mimetics as novel drug discovery platform for various pathologies.Curr. Med. Chem.202027213412344710.2174/092986732566618112010114730457046
   [Google Scholar]
8. Al-HoraniR.A. KaruturiR. VerespyS.III DesaiU.R. Synthesis of glycosaminoglycan mimetics through sulfation of polyphenols.Methods Mol. Biol.20151229496710.1007/978‑1‑4939‑1714‑3_725325944
   [Google Scholar]
9. Al-HoraniR.A. PonnusamyP. MehtaA.Y. GailaniD. DesaiU.R. Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIa.J. Med. Chem.201356386787810.1021/jm301338q23316863
   [Google Scholar]
10. Al-HoraniR.A. DesaiU.R. Designing allosteric inhibitors of factor XIa. Lessons from the interactions of sulfated pentagalloylg-lucopyranosides.J. Med. Chem.201457114805481810.1021/jm500311e24844380
    [Google Scholar]
11. Al-HoraniR.A. GailaniD. DesaiU.R. Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants.Thromb. Res.2015136237938710.1016/j.thromres.2015.04.01725935648
    [Google Scholar]
12. Al-HoraniR.A. AbdelfadielE.I. AfosahD.K. MorlaS. SistlaJ.C. MohammedB. MartinE.J. SakagamiM. BrophyD.F. DesaiU.R. A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding.J. Thromb. Haemost.201917122110212210.1111/jth.1460631397071
    [Google Scholar]
13. AbdelfadielE.I. GuntaR. VilluriB.K. AfosahD.K. SankaranarayananN.V. DesaiU.R. Designing smaller, synthetic, functional mimetics of sulfated glycosaminoglycans as allosteric modulators of coagulation factors.J. Med. Chem.20236674503453110.1021/acs.jmedchem.3c0013237001055
    [Google Scholar]
14. NakashimaH. IchiyamaK. HirayamaF. UchinoK. ItoM. SaitohT. UekiM. YamamotoN. OgawaraH. Sulfated pentagalloyl glucose (Y-ART-3) inhibits HIV replication and cytopathic effects in vitro and reduces HIV infection in hu-PBL-SCID mice.Antiviral Res.1996302-39510810.1016/0166‑3542(95)00903‑58783802
    [Google Scholar]
15. TiwariV. TandonR. SankaranarayananN.V. BeerJ.C. KohlmeirE.K. Swanson-MungersonM. DesaiU.R. Preferential recognition and antagonism of SARS-CoV-2 spike glycoprotein binding to 3-O-sulfated heparan sulfate.bioRxiv202010.1101/2020.10.08.331751
    [Google Scholar]
16. ElsteJ. KaltenbachD. PatelV.R. NguyenM.T. SharthiyaH. TandonR. MehtaS.K. VolinM.V. FornaroM. TiwariV. DesaiU.R. Inhibition of human Cytomegalovirus entry into host cells through a pleiotropic small molecule.Int. J. Mol. Sci.2020215167610.3390/ijms2105167632121406
    [Google Scholar]
17. GangjiR.N. SankaranarayananN.V. ElsteJ. Al-HoraniR.A. AfosahD.K. JoshiR. TiwariV. DesaiU.R. Inhibition of Herpes Simplex Virus-1 entry into human cells by Nonsaccharide Glycosaminoglycan Mimetics.ACS Med. Chem. Lett.20189879780210.1021/acsmedchemlett.7b0036430128070
    [Google Scholar]
18. MajmudarH. HaoM. SankaranarayananN.V. ZanottiB. VolinM.V. DesaiU.R. TiwariV. A synthetic glycosaminoglycan mimetic blocks HSV-1 infection in human iris stromal cells.Antiviral Res.201916115416210.1016/j.antiviral.2018.11.00730481525
    [Google Scholar]
19. GallegosK.M. TaylorC.R. RabulinskiD.J. Del ToroR. GirgisD.E. JourhaD. TiwariV. DesaiU.R. RamseyK.H.A. Synthetic, small, sulfated agent is a promising inhibitor of Chlamydia spp. infection in vivo.Front. Microbiol.20199326910.3389/fmicb.2018.0326930700982
    [Google Scholar]
20. Al-HoraniR.A. AfosahD.K. KarS. AliterK.F. MottamalM. Sulphated penta-galloyl glucopyranoside (SPGG) is glycosaminoglycan mimetic allosteric inhibitor of cathepsin G. RPS Pharm.Pharmacol. Rep.202321rqad00110.1093/rpsppr/rqad00136844783
    [Google Scholar]
21. PatelN.J. KaruturiR. Al-HoraniR.A. BaranwalS. PatelJ. DesaiU.R. PatelB.B. Synthetic, non-saccharide, glycosaminog-lycan mimetics selectively target colon cancer stem cells.ACS Chem. Biol.2014981826183310.1021/cb500402f24968014
    [Google Scholar]